NCT05381597View on ClinicalTrials.gov

5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 15, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Superficial Basal Cell CarcinomaSquamous Cell Carcinoma in Situ
Interventions
DRUG

Combination cream of 5-fluorouracil and calcipotriene

Apply the cream to the size of the lesion extending to the 0.5 cm area of skin surrounding the lesion.twice a day for 7 days and the treatment can be extended to 14 days based on evaluation at 7 days.

DRUG

5-fluorouracil cream

Apply the cream to the size of their lesion extending to the 0.5 cm area of skin surrounding the lesion twice daily for 28 days.

Trial Locations (1)

02118

RECRUITING

Boston Medical Center Dermatology Clinic, Boston

All Listed Sponsors
lead

Boston University

OTHER